secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0000950170-25-088592
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo files prospectus supplement for ATM offering of up to $8.0M
------------------------------------------------------------------

- Filed prospectus supplement for ATM offering of up to $8,037,381 in common stock via Roth Capital Partners.
- As of June 20, had sold 481,828 shares for gross proceeds of $3,765,143 under the April 2025 Sales Agreement.
- Offering is registered under Form S-3 (File No. 333-284969); legal opinion from Paul Hastings LLP filed as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025088592/0000950170-25-088592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025088592/apvo-20250620.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-088592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer